YOSHIO YAMAOKA to Prospective Studies
This is a "connection" page, showing publications YOSHIO YAMAOKA has written about Prospective Studies.
Connection Strength
0.242
-
Efficacy of Omeprazole, Tetracycline, and 4 Times Daily Dosing of Amoxicillin in Helicobacter pylori Eradication in Limited Resource Area in Bhutan: A Prospective Randomized Trial (BHUTAN Study). Asian Pac J Cancer Prev. 2020 Apr 01; 21(4):1109-1114.
Score: 0.075
-
Helicobacter pylori antibiotic susceptibility patterns in Bangladesh: Emerging levofloxacin resistance. J Infect Dev Ctries. 2016 Mar 31; 10(3):245-53.
Score: 0.057
-
Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pyloricagA genotype. Scand J Gastroenterol. 2005 May; 40(5):530-9.
Score: 0.027
-
Fourteen-day vonoprazan-based bismuth quadruple therapy for H. pylori eradication in an area with high clarithromycin and levofloxacin resistance: a prospective randomized study (VQ-HP trial). Sci Rep. 2024 04 18; 14(1):8986.
Score: 0.025
-
Simultaneous detection of Helicobacter pylori infection comparing between white light and image-enhanced endoscopy. BMC Gastroenterol. 2024 Jan 26; 24(1):46.
Score: 0.024
-
Gut-Homing CD4+ T Cells Are Associated with the Activity of Gastritis in HIV-Infected Adults. AIDS Res Hum Retroviruses. 2020 11; 36(11):910-917.
Score: 0.019
-
Thoughts about populations with unexpected low prevalences of Helicobacter pylori infection. Trans R Soc Trop Med Hyg. 2007 Sep; 101(9):849-51.
Score: 0.008
-
A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication. Am J Gastroenterol. 2005 Nov; 100(11):2387-92.
Score: 0.007